ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,977Medicare Part D Prescriptions Filled, Including Refills

Rank: 572 out of 3593

$362K Total Retail Price of All Prescriptions

Rank: 1102 out of 3593

382 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

25% of this provider’s 382 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 7,349 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
AMLODIPINE BESYLATE 744 631 1 3
LISINOPRIL 670 572 2 2
SIMVASTATIN 621 465 3 1
OMEPRAZOLE 411 301 4 5
HYDROCODONE-ACETAMINOPHEN 340 195 S3 5 7
METOPROLOL TARTRATE 279 206 6 8
AMOXICILLIN 247 127 7 128
METOPROLOL SUCCINATE 239 193 8 19
IBUPROFEN 232 162 9 43
METFORMIN HCL 217 159 10 6
TRAMADOL HCL 205 114 11 17
CARVEDILOL 194 160 12 23
ZOLPIDEM TARTRATE 186 107 13 12
TRIAMTERENE-HCTZ 168 156 14 66
MELOXICAM 142 91 15 29
AZITHROMYCIN 136 89 16 34
CIPROFLOXACIN HCL 121 79 17 52
LISINOPRIL-HYDROCHLOROTHIAZIDE 118 41 18 26
LEVOTHYROXINE SODIUM 118 80 18 4
FUROSEMIDE 113 105 20 9
CLONIDINE HCL 110 88 21 41
METFORMIN HCL ER 109 78 22 67
ALLOPURINOL 108 78 23 35
GLIMEPIRIDE 107 93 24 44
CLOPIDOGREL 106 87 25 30
PREDNISONE 101 64 26 49
LANTUS 99 82 27 57
LOSARTAN POTASSIUM 96 75 28 14
LOSARTAN-HYDROCHLOROTHIAZIDE 93 80 29 48
PROAIR HFA 87 53 30 54
GABAPENTIN 83 71 31 16
PRAVASTATIN SODIUM 75 53 32 13
PLAVIX 73 57 33 42
DOXAZOSIN MESYLATE 69 62 34 63
DONEPEZIL HCL 69 58 34 31
AMLODIPINE BESYLATE-BENAZEPRIL 62 58 36 65
NOVOLOG 58 41 37 134
FLUOCINONIDE 57 45 38 401
LEVOFLOXACIN 56 46 39 116
POTASSIUM CHLORIDE 55 52 40 24
VALPROIC ACID 55 26 40 359
QUETIAPINE FUMARATE 54 34 42 89
NYSTATIN-TRIAMCINOLONE 51 31 43 203
GLYBURIDE 51 41 R 43 55
NAPROXEN 50 36 45 68
MIRTAZAPINE 50 40 45 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.